SOHO Italy

www.sohoitaly.it

 

SOHO 4th Italian Conference
G

SOHO Italy 2022: Phase 3 SELECT-MDS-1 Study - A Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene + Aza vs. Placebo + Aza in Newly Diagnosed Adult Patients Selected for RARA+ HR-MDS

By SOHO 4th Italian Conference FEATURING Giovanni Marconi
By SOHO 4th Italian Conference FEATURING Giovanni Marconi
42 views
November 28, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
MDS and MPN
08:27

SOHO Italy 2022: Epigenetic Changes in MDS-Derived Mesenchymal Strom…

SOHO 4th Italian Conference

S. Giallongo

12 views
20:30

SOHO Italy 2022: Treatment of HR-MDS in 2022 at MDACC

SOHO 4th Italian Conference

G. Garcia-Manero

59 views
06:12

SOHO Italy 2022: Phase 3 SELECT-MDS-1 Study - A Randomized, Double-B…

SOHO 4th Italian Conference

G. Marconi

42 views
13:27

SOHO Italy 2022: How I Treat MF Candidates for Transplant

SOHO 4th Italian Conference

N. Polverelli

60 views
10:38

SOHO Italy 2022: Essential Thrombocythemia

SOHO 4th Italian Conference

A. Tefferi

313 views